Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $3.12 Million - $3.41 Million
10,100 Added 72.66%
24,000 $7.73 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $2.39 Million - $2.91 Million
9,100 Added 189.58%
13,900 $4.34 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $672,175 - $811,400
2,500 Added 108.7%
4,800 $1.36 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $588,110 - $663,458
2,300 New
2,300 $662,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.